DIGGIT: a Bioconductor package to infer genetic variants driving cellular phenotypes
Mariano J Alvarez1, James C Chen2, Andrea Califano1
1Department of Systems Biology and.
Bioinformatics (Oxford, England)
|September 5, 2015
Summary
This study introduces a new method to find genetic causes of human diseases by analyzing regulatory networks. The Driver-gene Inference by Genetical-Genomic Information Theory (diggit) R package helps identify upstream genes driving disease.
Area of Science:
- Genomics
- Systems Biology
- Bioinformatics
Background:
- Identifying driver mutations in human diseases is challenging due to limited cohort sizes and statistical model constraints.
- Understanding the genetic basis of diseases requires methods that can systematically discover causal alterations.
Purpose of the Study:
- To present a novel method for the systematic discovery of genetic alterations that causally determine human diseases.
- To implement this method as an R-system package called Driver-gene Inference by Genetical-Genomic Information Theory (diggit).
Main Methods:
- Prioritizing genes upstream of functional disease drivers within regulatory networks.
- Inferring regulatory networks de novo from experimental data.
- Utilizing genetical-genomic information theory for driver gene discovery.
Main Results:
- The development and implementation of the diggit R package for driver gene discovery.
- A systematic approach to identify causal genetic determinants of disease.
Conclusions:
- The diggit package offers a new tool for researchers to identify driver mutations and understand disease etiology.
- This method enhances the discovery of genetic alterations by focusing on upstream regulatory elements.
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
98
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
98
Genetic Screens
5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
Genetic Variation
1.6K
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
Genes exist in different versions called alleles,...
1.6K
Incomplete Dominance
32.6K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.6K
Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Genome-wide Association Studies-GWAS
16.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.7K


